CAPITAL STOCK |
12 Months Ended |
|---|---|
Dec. 31, 2022 | |
| Equity [Abstract] | |
| CAPITAL STOCK |
NOTE I – CAPITAL STOCK
The Company has authorized 15,000,000 shares of preferred stock, with a par value of $.001 per share. Of those shares, the Company has designated 215 shares as Series A preferred stock and 567 shares as Series B preferred stock. At December 31, 2022, there were 181 shares of Series A and 52 shares of Series B outstanding. At December 31, 2021, there were 185 shares of Series A and 52 shares of Series B outstanding
As of December 31, 2022 and December 31, 2021, the Company has authorized 475,000,000 shares of common stock with a par value of $.001 per share. As of December 31, 2022 and 2021, the Company had 299,212,282 and 136,311,335 shares of common stock issued and outstanding, respectively.
During the year ended December 31, 2022, the Company issued to VDA 162,900,947 of Company Common Stock and a warrant to purchase 105,380,666 additional shares of Common Stock. During the year ended December 31, 2021, the Company issued 320,844 shares of common stock to directors for services performed during 2020. These shares were valued at $18,000, which approximated the fair value of the shares when they were issued.
During the years ended December 31, 2022 and 2021, no warrants were exercised.
During the years ended December 31, 2022 and 2021, no shares of Series A or B preferred stock were converted to shares of common stock.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|